Fisher & Paykel Healthcare back in favour
Investors are showing a renewed interest in Fisher & Paykel Healthcare, the company says, and are wising up to the bottom line benefits of a weaker New Zealand dollar.
Fisher & Paykel Healthcare (FPH) was asked by the ASX to explain the recent increase in its stock price, from $A2.63 at close last Tuesday to A$2.90 yesterday.
The company, which is dual listed on the ASX and NZX, says in response that it believes the market may have recognised two factors influencing its...
10/22/2008 3:35:50 PM
National Business Review (NBR) New Zealand - Business, News, Arts, Media, Share Market & More -
|
